Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma
Abstract Vitreoretinal large B-cell lymphoma (VR-LBCL) is a rare hematologic malignancy. It is classified as primary (PVR-LBCL) or secondary (SVR-LBCL) based on the initial site of manifestation. Owing to limited prospective data and absent standardized guidelines, treatment remains challenging. Thi...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2026-02-01
|
| シリーズ: | Scientific Reports |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1038/s41598-026-37804-4 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
